Cash supplement: China Gewang Biotechnology files for a $12 million Nasdaq IPO

China Gewang Biotechnology, which sells nutritional supplements in China, filed on Monday with the SEC to raise up to $12 million in an initial public offering on a major exchange. The company is currently listed on the OCTQB under the symbol CGWB.

The Guangzhou City, China-based company was founded in 2010 and booked $21 million in sales for the 12 months ended August 31, 2016. It plans to list on the Nasdaq under the symbol CGWB. ViewTrade is the sole bookrunner on the deal. No pricing terms were disclosed.